Exercise training in heart failure: reduction in angiotensin II, sympathetic nerve activity, and baroreflex control.
Negrão
Carlos E
CE
Middlekauff
Holly R
HR
D000804:Angiotensin II / Q000097:blood / Q000378:metabolism*; D000818:Animals; D017704:Baroreflex; D002908:Chronic Disease; D004195:Disease Models, Animal; D015536:Down-Regulation; D005081:Exercise Therapy; D006333:Heart Failure / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D006439:Hemodynamics; D006801:Humans; D007668:Kidney / Q000294:innervation*; D008526:Medulla Oblongata / Q000378:metabolism / Q000503:physiopathology; D012333:RNA, Messenger / Q000378:metabolism; D044140:Receptor, Angiotensin, Type 1 / Q000235:genetics / Q000378:metabolism; D013564:Sympathetic Nervous System / Q000503:physiopathology*
D012333:RNA, Messenger; D044140:Receptor, Angiotensin, Type 1; D000804:Angiotensin II